Search

everythinglearnresearchcommunity

for

Search:↓

Adding cerium(III) chloride to Grignard reagents improves the making of compounds that could treat prostate issues and hair loss.

AMP-303 safely increases hair growth in men with hair loss.

The combination of tadalafil and finasteride improves urinary symptoms and erectile function in men with enlarged prostates.

dAR-6–1 is a promising new treatment for hair loss that works better than minoxidil.

Three specific 4-azasteroid-2-oximes showed strong enzyme inhibition, but less than finasteride.

Androsterone and finasteride have different solid forms, with new findings correcting previous errors and identifying a new form.

Red ginseng extract (GS-E3D) may promote hair growth and has antioxidant and anti-inflammatory properties.

CB-03-01 is a promising skin cream for treating hormone-related skin problems without causing harmful body-wide effects.

The new compounds may be more effective and cheaper than current treatments for conditions like baldness.

New steroids were patented as effective for treating acne, hair loss, and other conditions related to hormones.

New pregnane derivatives were more effective than finasteride at inhibiting a key enzyme for male pattern baldness.

Finasteride doesn't affect oral testosterone undecanoate, and high DHT levels may cause acne, prostate issues, and hair loss.

Testosterone affects androgen receptors and lipid storage in cells, while DHEA does not convert to testosterone or affect these receptors in the same way.

Manipulating 5α-reductase type 2 can affect liver fat production and glucocorticoid effects.

The FDA rejected a testosterone drug again due to safety concerns.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

Flutamide and a new synthetic steroid affected brain and prostate chemicals and showed potential for treating androgen-related conditions and epilepsy.

SDG helps reduce BPH effects in rats.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

Enzymatic synthesis improved the water solubility of the flavonoid baicalin, which may help treat hair loss conditions.

20(S)-Protopanaxadiol-aglycone may help prevent and treat prostate cancer by reducing androgen receptor activity.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

Three compounds were found to inhibit a prostate disease-related enzyme and reduce prostate size more effectively than the current treatment, suggesting they could be used for treating benign prostatic hyperplasia.

Glioblastoma cells can make androgens, which might help the tumor grow.

Prostaglandin D2 increases testosterone production in skin cells through a process involving reactive oxygen species, which could be a new target for treating hair loss and other skin conditions driven by testosterone.